Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/12/1010   
Active ingredient: Ataluren
Indication: Treatment of Becker muscular dystrophy
Sponsor: PTC Therapeutics International Limited
77 Sir John Rogerson’s Quay, Dublin 2, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/07/2012 Orphan designation EMA/OD/032/12 (2012)4775 of 04/07/2012
02/08/2013 Change of name and/or address of sponsor
05/08/2014 Change of name and/or address of sponsor
10/06/2015 Transfer of orphan designation EMA/OD/032/12/T/01 (2015)3930 of 05/06/2015